Standout Papers

Pembrolizumab plus axitinib versus sunitinib monotherapy as first-line treatment of advance... 2019 2026 2021 2023 468
  1. Pembrolizumab plus axitinib versus sunitinib monotherapy as first-line treatment of advanced renal cell carcinoma (KEYNOTE-426): extended follow-up from a randomised, open-label, phase 3 trial (2020)
    Thomas Powles, Elizabeth R. Plimack et al. The Lancet Oncology
  2. Cancer-associated fibroblasts induce epithelial–mesenchymal transition of bladder cancer cells through paracrine IL-6 signalling (2019)
    Cassandra Ringuette Goulet, Audrey Champagne et al. BMC Cancer
  3. A Phase 2/3 Prospective Multicenter Study of the Diagnostic Accuracy of Prostate Specific Membrane Antigen PET/CT with 18 F-DCFPyL in Prostate Cancer Patients (OSPREY) (2021)
    Kenneth J. Pienta, Michael A. Gorin et al. The Journal of Urology
  4. Diagnostic Performance of 18F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase III, Multicenter Study (2021)
    Michael J. Morris, Steven P. Rowe et al. Clinical Cancer Research
  5. Open-Label, Single-Arm, Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Non–Clear Cell Renal Cell Carcinoma (2021)
    David F. McDermott, Jae‐Lyun Lee et al. Journal of Clinical Oncology

Immediate Impact

6 by Nobel laureates 9 from Science/Nature 61 standout
Sub-graph 1 of 24

Citing Papers

The hallmarks of cancer immune evasion
2024 Standout
Covalent targeted radioligands potentiate radionuclide therapy
2024 StandoutNature
1 intermediate paper

Works of Frédéric Pouliot being referenced

A Phase 2/3 Prospective Multicenter Study of the Diagnostic Accuracy of Prostate Specific Membrane Antigen PET/CT with 18 F-DCFPyL in Prostate Cancer Patients (OSPREY)
2021 Standout
Pembrolizumab plus axitinib versus sunitinib monotherapy as first-line treatment of advanced renal cell carcinoma (KEYNOTE-426): extended follow-up from a randomised, open-label, phase 3 trial
2020 Standout

Author Peers

Author Last Decade Papers Cites
Frédéric Pouliot 2675 1761 1381 189 4.3k
Noriko Motoi 3256 1394 2497 189 5.5k
Kazuko Sakai 2239 1969 2680 238 5.3k
Hyo Sup Shim 2987 1481 2305 159 5.0k
Sylvie Lantuéjoul 3603 2035 3076 151 6.6k
Begoña Mellado 2130 1931 1861 178 4.6k
Andres Jan Schrader 1978 1114 1149 160 3.7k
Mauro Papotti 2633 1317 1656 95 4.4k
Wendy A. Cooper 2814 1906 2455 124 5.4k
Tomoyuki Yokose 3266 1185 2603 270 6.5k
Masahiro Yao 2833 2897 1037 264 5.6k

All Works

Loading papers...

Rankless by CCL
2026